InvestorsHub Logo
Followers 1
Posts 183
Boards Moderated 0
Alias Born 07/30/2014

Re: salgovernale69 post# 22660

Thursday, 09/25/2014 11:01:12 AM

Thursday, September 25, 2014 11:01:12 AM

Post# of 48316
I think 1-1.50 is very attainable for the short term (end of year). These small cap biotech stocks run on investor sentiment and data. So I think if we get very good data supporting our claim to turn non responders into responders then we will run hard for 2-3 days afterwards. That's without taking into acct a partnership agreement. Partnership could mean another 50-100 percent increase ftom 1-1.50. So 2-3 dollars by end of year with excellent data and partnership agreement with other milestones in between.